New insights into certain catalytic enzymes formed by bacteria to break down antibiotics may lead to the design of drugs better equipped to combat resistant bacteria.
New insights from neutron analysis of glaucoma drugs and their enzyme target may help scientists design drugs that more effectively target aggressive cancers.
New insights from neutron analysis of glaucoma drugs and their enzyme target may help scientists design drugs that more effectively target aggressive cancers.